Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,917,438
+$1,772,455 QoQ
Shares Held
6,601
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#1,392
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. LLY ranks #4 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,917,438 | 6,601 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,144,983 | 6,681 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,190,684 | 6,691 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,147,198 | 6,746 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,317,174 | 6,821 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,736,770 | 6,946 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,032,408 | 7,814 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $8,105,465 | 9,149 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,467,589 | 6,039 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $4,746,333 | 6,101 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,139,897 | 7,102 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,781,395 | 7,040 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,302,088 | 7,041 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $2,057,772 | 5,992 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,192,113 | 5,992 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,942,363 | 6,007 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,962,239 | 6,052 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,217,076 | 7,742 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,820,842 | 6,592 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,892,761 | 8,192 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,692,939 | 7,376 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $964,551 | 5,163 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $652,228 | 3,863 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||